Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

August 26, 2009Open Access

Ver artículo completo

Seize the opportunity

DCDouglas P. ClarkJohns Hopkins University

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Molecularly targeted agents are increasingly utilized to treat cancer. Unfortunately, biomarkers to guide this therapy are infrequently applied to FNA samples.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Douglas P. Clark (Wed,) studied this question.

synapsesocial.com/papers/6a1db6076f8771f2e95cd15d https://doi.org/https://doi.org/10.1002/cncy.20045

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Seize the opportunity | Synapse

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Total RNA yield and microarray gene expression profiles from fine‐needle aspiration biopsy and core‐needle biopsy samples of breast carcinoma2003 · 176 citations
2

Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease1999 · 2,795 citations

3The Cytologic Diagnosis of Cancer1964 · 19 citations

4Mapping normal and cancer cell signalling networks: towards single-cell proteomics2006 · 325 citations

5Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers2007 · 99 citations